Allied Healthcare Products Inc (AHPI)
1.885
+0.16 (+8.96%)
USD |
NASDAQ |
May 17, 14:15
Allied Healthcare Products Free Cash Flow: -2.200M for Dec. 31, 2021
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2021 | -2.200M |
| September 30, 2021 | -0.8402M |
| June 30, 2021 | -3.951M |
| March 31, 2021 | -4.715M |
| December 31, 2020 | -2.722M |
| September 30, 2020 | -3.026M |
| June 30, 2020 | 0.0298M |
| March 31, 2020 | 1.43M |
| December 31, 2019 | 0.3892M |
| September 30, 2019 | -0.1704M |
| June 30, 2019 | 0.0593M |
| March 31, 2019 | 0.1412M |
| December 31, 2018 | -1.024M |
| September 30, 2018 | -0.6214M |
| June 30, 2018 | -0.8596M |
| March 31, 2018 | -1.220M |
| December 31, 2017 | -0.8464M |
| September 30, 2017 | -1.120M |
| June 30, 2017 | -0.708M |
| March 31, 2017 | -0.93M |
| December 31, 2016 | -0.7913M |
| September 30, 2016 | -0.6334M |
| June 30, 2016 | -0.3363M |
| March 31, 2016 | -0.094M |
| December 31, 2015 | 0.0996M |
| Date | Value |
|---|---|
| September 30, 2015 | 0.2736M |
| June 30, 2015 | 0.6732M |
| March 31, 2015 | 0.2984M |
| December 31, 2014 | -0.7452M |
| September 30, 2014 | -1.353M |
| June 30, 2014 | -2.321M |
| March 31, 2014 | -2.798M |
| December 31, 2013 | -2.294M |
| September 30, 2013 | -2.060M |
| June 30, 2013 | -1.347M |
| March 31, 2013 | -1.798M |
| December 31, 2012 | -1.424M |
| September 30, 2012 | -0.7781M |
| June 30, 2012 | -1.228M |
| March 31, 2012 | 0.5687M |
| December 31, 2011 | -0.0374M |
| September 30, 2011 | 0.7052M |
| June 30, 2011 | 1.129M |
| March 31, 2011 | 2.413M |
| December 31, 2010 | 3.622M |
| September 30, 2010 | 2.980M |
| June 30, 2010 | 3.180M |
| March 31, 2010 | 1.099M |
| December 31, 2009 | -1.805M |
| September 30, 2009 | -1.905M |
Free Cash Flow Range, Past 5 Years
-4.715M
Minimum
Mar 2021
1.43M
Maximum
Mar 2020
-1.156M
Average
-0.8464M
Median
Dec 2017
Free Cash Flow Benchmarks
| MannKind Corp | -82.77M |
| Nektar Therapeutics | -440.32M |
| Novavax Inc | -489.18M |
| Intercept Pharmaceuticals Inc | -7.14M |
| Karyopharm Therapeutics Inc | -119.22M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -1.142M |
| Cash from Financing (Quarterly) | 1.064M |
| Free Cash Flow Per Share (Quarterly) | -0.2846 |
| Free Cash Flow to Equity (Quarterly) | -2.206M |
| Free Cash Flow to Firm (Quarterly) | -1.100M |
| Free Cash Flow Yield | -29.06% |